Adjuvant vitamin E and ovarian cancer Public Deposited

http://ir.library.oregonstate.edu/concern/undergraduate_thesis_or_projects/6969z229w

Descriptions

Attribute NameValues
Creator
Abstract or Summary
  • Cisplatin (CDDP) is a highly active platinum-containing chemotherapeutic agent for use against solid tumors, including ovarian. However, like most antitumor agents, CDDP use is accompanied by non-tumor tissue toxicities leading to unwanted side effects, including neuropathy. To date, the mechanism(s) for these side effects are undefined. However, the clinical features of CDDP neurotoxicity resemble those seen in vitamin E (alpha-tocopherol, aT) deficiency neuropathy. Using a preclinical model of epithelial ovarian cancer we tested the hypothesis that (1) CDDP depletes aT by an oxidative stress mechanism whereby platinum acts as a catalyst for lipid peroxidation thereby leading to aT-deficiency neuropathy, (2) adjuvant aT will prevent CDDP-mediated lipid peroxidation and aT depletion, and (3) adjuvant aT will improve CDDP antitumor efficacy. Tumor-bearing F344 rats were assigned to one of four treatment regimens: (1) saline, (2) aT, (3) CDDP, or (4) CDDP + aT. Our data indicates CDDP increases lipid peroxidation and decreases plasma and tissue aT levels and that adjuvant aT prevents CDDP-induced lipid peroxidation and aT depletion. In addition, adjuvant aT decreased tumor tissue proliferation and decreased tumor burden more than 5-fold, compared to CDDP alone. These data are the first to document the ability of adjuvant aT to improve chemotherapeutic antitumor efficacy and improve antioxidant/oxidative stress status in an immune competent tumor-bearing animal.
Resource Type
Date Available
Date Issued
Degree Level
Degree Name
Degree Field
Degree Grantor
Commencement Year
Advisor
Non-Academic Affiliation
Rights Statement
Funding Statement (additional comments about funding)
Language
Replaces
Additional Information
  • description.provenance : Submitted by Alysha Hartman (hartmaal@onid.orst.edu) on 2015-01-14T19:26:56ZNo. of bitstreams: 2AEHartman_URSA.djm2.pptx: 1196796 bytes, checksum: d82299f8f73b149e5fdd3ec91addb3a6 (MD5)AEHartman_URSA.djm2.pdf: 1909413 bytes, checksum: 651d7411061a87cda12ee5757f460b74 (MD5)
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2015-01-14T19:39:48Z (GMT) No. of bitstreams: 2AEHartman_URSA.djm2.pptx: 1196796 bytes, checksum: d82299f8f73b149e5fdd3ec91addb3a6 (MD5)AEHartman_URSA.djm2.pdf: 1909413 bytes, checksum: 651d7411061a87cda12ee5757f460b74 (MD5)
  • description.provenance : Made available in DSpace on 2015-01-14T19:39:48Z (GMT). No. of bitstreams: 2AEHartman_URSA.djm2.pptx: 1196796 bytes, checksum: d82299f8f73b149e5fdd3ec91addb3a6 (MD5)AEHartman_URSA.djm2.pdf: 1909413 bytes, checksum: 651d7411061a87cda12ee5757f460b74 (MD5)

Relationships

Parents:

This work has no parents.

Last modified

Downloadable Content

Download PDF

Items